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Risk factors for defaulting from tuberculosis treatment: 
a prospective cohort study of 301 cases in The Gambia
P. C. Hill,* W. Stevens,* S. Hill,* J. Bah,* S. A. Donkor,* A. Jallow,† C. Lienhardt‡
* Department of Tuberculosis, Medical Research Council Laboratories, Banjul, † Department of Disease Control, Gambia 
S U M M A R Y
Government, Banjul, The Gambia; ‡ Tuberculosis Unit, Institut de Recherche pour le Développement, Dakar, Senegal
SETTING: An urban tuberculosis (TB) clinic, The Gambia.
OBJECTIVE: To identify patient characteristics associ-
ated with increased rates of defaulting from treatment,
specifically knowledge and cost factors amenable to
intervention.
DESIGN: Prospective cohort study of TB cases at least
15 years of age commencing treatment, interviewed by
semi-structured questionnaire and followed for atten-
dance at thrice-weekly directly observed treatment (DOT).
RESULTS: Of 301 patients, 76 (25.2%) defaulted from
treatment and 25 did not return for treatment. The de-
faulting rate was higher among those who said they were
uncertain that their treatment would work (HR 3.64;
95%CI 1.42–9.31, P  0.007) and among those who
incurred significant time or money costs travelling to
receive treatment (HR 2.67; 95%CI 1.05–6.81; P 
0.04). These factors had differing effects with respect to
time: uncertainty over treatment success was important
in the first 90 days of treatment, while increased cost of
travelling to the clinic was important after 90 days.
CONCLUSION: In The Gambia, risk groups for default-
ing can be recognised at the start of treatment and are at
highest risk at different times. Home-based self-adminis-
tration of medications after 3 months of DOT should be
considered as confidence in treatment success rises, and
the costs of travelling to receive treatment start to take
their toll.
KEY WORDS: The Gambia; tuberculosis; defaulting;
cost; knowledge
TUBERCULOSIS (TB) in The Gambia is on the in-
crease, with all-form case notification rising from 82
per 100 000 population per year in 1994 to 145/
100 000/year in 2003.1 The rate of permanent de-
faulting from treatment has been consistently above
10% over this time (10–17%), although the rate of
resistance to one or more first-line drugs is low (4%
in 1999).2 Facilities for diagnosis and treatment are
provided through nine divisional health centres and a
sanatorium. Since 2000, Greater Banjul, the largest ur-
ban centre, has experienced rapid population growth
and an increasing incidence of TB (176/100 000 in
2003). One major clinic (Serrekunda) in Greater Ban-
jul manages the diagnosis and treatment of almost
half the cases for the whole country (930/1985 in
2003), and has experienced increasing congestion and
increasing rates of defaulting from treatment.
Following investigations into the qualitative deter-
minants of TB control,3,4 we investigated risk factors
for defaulting from treatment at the main TB clinic in
Greater Banjul, to provide important information for
planning the readjustment of services. Most previous
investigations of risk factors for defaulting have used
a case control design. Cohort studies are less common
but, at least in industrialised countries, have shown
that certain risk groups for defaulting can be recog-
nised at the start of treatment.5 We used a cohort
study design to identify patient characteristics that
lead to higher rates of defaulting from treatment,
especially patient knowledge and cost factors that
might be amenable to intervention.
METHODS
Study participants
New cases of TB aged 15 years who started their
treatment between 16 October 2002 and 26 Novem-
ber 2003 were recruited at the main public TB clinic
in Greater Banjul. A case was defined as an individual
placed on full course TB treatment, and included smear-
positive (Ziehl-Neelsen stain), smear-negative and
extra-pulmonary cases. Retreatment cases were not eli-
gible for the study. The majority of smear-negative
cases are referred with chest X-ray findings consistent
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with TB. Cases were invited to take part in the study
within 3 weeks of starting treatment.
Study participants received standard TB treatment
according to current practice in The Gambia, consist-
ing of three times weekly directly observed treatment
(DOT), with 2 months of rifampicin (RMP), isoniazid
(INH), pyrazinamide and ethambutol, followed by at
least 4 months of RMP and INH (8-month treatment
for extra-pulmonary TB [EPTB]). Medications were
administered by Leprosy/TB Inspectors (LTIs), who
are members of the local community trained specifi-
cally in the diagnosis and treatment of TB.
Data collection
Study participants answered a structured questionnaire
administered in their own language by one of two
trained health workers. Information collected in the
questionnaire included basic demographic data (age,
sex, ethnicity), knowledge of TB, financial resources,
and the costs experienced in accessing treatment (in-
cluding travelling time). After data collection, partic-
ipants were provided with counselling on the nature
and treatment of TB, with specific reference to knowl-
edge deficits identified during administration of the
questionnaire.
Information on patients’ attendance for treatment
was recorded in a separate register. This study was a
prospective cohort study with a primary outcome of
defaulting, which was defined as failure to present for
DOT on three consecutive occasions. Patients were
defined as permanent defaulters if they did not return
to complete their treatment. LTIs traced patients in
their homes where possible.
All patients included in the study provided
signed informed consent. The study was approved
by the combined Gambia government/MRC ethics
committee.
Data management and analysis
All data were double-entered into an Access data-
base (Microsoft Corp, Redmond, WA, USA), veri-
fied and checked for errors. Data were analysed by
Cox proportional hazards regression to assess the
relationship between risk factors and rate of default-
ing. Results were reported as unadjusted and ad-
justed hazard ratios and their 95% confidence inter-
vals (CI). Variables for the multivariable model,
apart from age (selected a priori), were included if
they showed a univariate association with defaulting
at the P  0.2 level of significance. Because, for sev-
eral factors, there was failure to meet the propor-
tionality assumption necessary for the Cox regres-
sion over the whole treatment period, two separate
analyses were conducted with time split at 90 days.
Kaplan-Meier curves were created for key risk fac-
tors. All statistical analyses were conducted using
Stata software (Version 8; Stata Corp, College Sta-
tion, TX, USA).
RESULTS
From 16 October 2002 to 26 November 2003, 348
TB patients were interviewed; 301 of these (86%) had
complete recruitment and follow-up information.
The characteristics of the 301 patients are presented
in Table 1, together with the characteristics of those
who were not interviewed over the course of the
study, according to the clinic records. Almost one third
of the eligible patients were included in the study and
appeared representative for age and sex and for a pul-
monary vs. extra-pulmonary diagnosis. However, spu-
tum smear-positive cases were over-represented among
the pulmonary cases in the study. No clear reasons for
this were identified.
The outcomes of the patients in the study are pre-
sented in Figure 1. There were 76 (25.2%) defaulters.
The mean time to default was 110 days (median 115;
range 21–195 days). Twenty-five patients (33% of the
defaulters; 8% overall) were permanent defaulters;
21 of these patients were found to be alive, but four
could not be located due to incorrect home addresses.
An assessment of various possible risk factors for
defaulting is presented in Table 2, split on time to be-
fore 90 days and after 90 days, as described in the
methods. Defaulting did not depend on sex, ethnic
group or employment status. Patients in the 26–40
years age group had a higher rate of defaulting in the
first 90 days of treatment than the other age groups,
although this was not statistically significant. Those
Table 1 Characteristics of 301 study patients and the 
eligible clinic population (n  937)
Characteristic 
Study
participants
% (n) 
Eligible clinic
population 
% (n)
Sex
Female 34.2 (103) 34.2 (320)
Male 65.8 (198) 65.9 (617)
Age, years
15–25 32.9 (99) 28.2 (265)
26–40 42.9 (127) 41.7 (391)
40 24.9 (75) 30.0 (281)
Type of disease
Smear-positive 83.4 (251) 67.5 (628)
Smear-negative 11.0 (33) 19.0 (178)
Extra-pulmonary 5.7 (17) 5.7 (53)
Figure 1 Outcome of study participants.
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with extra-pulmonary disease, although small in num-
ber, had a higher rate of defaulting in the first 90 days
than those with pulmonary disease; this was signifi-
cant in the multivariable model (P  0.03). As the
fact that extra-pulmonary cases each contributed 8
months of time to the study did not affect the results,
a separate analysis was not required.
Other risk factors were combined on the basis of
the questionnaire. Those with a family history of dis-
ease included those with a family history of TB or any
other severe illness (such as severe malaria); they were
not more likely to default. Key TB knowledge included
an understanding that TB can be given to someone
else, that it can kill and that it is curable. Those lack-
ing in one or more key knowledge areas surprisingly
had a lower rate of defaulting in the first 90 days of
treatment, although this was not statistically signifi-
cant. In contrast, those who were not certain that
their treatment would be successful were at an in-
creased risk of defaulting in the first 90 days; this re-
mained statistically significant in the multivariable
analysis (P  0.007). Notably, this was not a signifi-
cant risk factor for defaulting after 90 days.
Pre-treatment costs included visits to traditional
healers, other alternative health care providers or
health clinics before TB was diagnosed. Those with
greater pre-treatment costs did not have a signifi-
cantly increased rate of defaulting. Cases who had to
travel for more than half an hour or incurred more
than 6 Dalasis (0.16 Euros, equivalent to an average
taxi fare in The Gambia) to reach the treatment cen-
tre were at an increased risk of defaulting after 90
days of treatment, compared to those with neither
problem; this was statistically significant in the multi-
variable analysis (P  0.04).
Financial stress during treatment was defined as a
loss of more than 3 days’ work per week, the need
to pay children’s school fees, or having to borrow
money over the period of treatment, in the absence of
financial help from others. Financial stress was not
associated with defaulting.
Kaplan-Meier plots of time to defaulting according
to level of certainty of treatment success (A) or diffi-
culty in travel to clinic (B) are presented in Figure 2.
The difference in the rate of defaulting for each risk fac-
tor, compared with those without the risk factor, was
consistent with the findings of the Cox regression:
both had a divergence that began at approximately 3
weeks, increasing most dramatically in the first 90
days for those with uncertainty about treatment out-
come, and increasing more slowly during the first 90
days with respect to significant travel time or cost of
travel to the clinic.
DISCUSSION
In this prospective cohort study of defaulting from TB
treatment in The Gambia, we found that the rate of
defaulting significantly increased in TB patients who
were uncertain that their treatment would work and
in those who incurred significant time or money costs
when travelling to receive treatment. These two fac-
tors had differing effects with respect to time: uncer-
tainty over treatment success was important in the first
90 days of treatment, while increased costs of travel-
ling to the clinic became important after 90 days.
Subjects with extra-pulmonary disease were also at a
higher risk of defaulting than those with pulmonary
disease. None of the following factors had any effect
on defaulting: age, sex, ethnicity, employment status,
previous experience of a severe disease or reported
financial stress while on treatment.
Knowledge about TB disease and its treatment at
the time of defaulting have been shown to be impor-
tant in case control studies in Africa.6,7 In our study,
however, those with an essential knowledge deficit
were not more likely to default from treatment than
those with no deficit. Strangely, it appeared that the
opposite might be true, although the effect was not
statistically significant. Another cohort study of 135
patients in Malaysia found misconceptions and lim-
ited knowledge about TB among the participants, but
found also that these had no effect on defaulting.8
These findings may be an artefact due to the informa-
tion bias introduced by health workers endeavouring
Figure 2 Kaplan-Meier plots of time to defaulting for key risk
factors, adjusted for possible confounding variables.
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to correct knowledge deficits identified in the ques-
tionnaire. This is a weakness inherent in the design of
a cohort study, where it is considered unethical to ig-
nore knowledge deficits when found. Perhaps a more
accurate reflection of health belief was the ‘uncertainty
of treatment success’, which was significantly associ-
ated with defaulting in the first 90 days. It is quite rea-
sonable to surmise that improving symptoms would
lead those with uncertainty to become more confident
of treatment success, explaining the loss of a differ-
ence after 90 days.
Others have also shown increased rates of default-
ing associated with difficulty in getting to treatment.9
Our study, combining cost in terms of time and
money spent, shows that in The Gambia this risk be-
comes particularly important after the first 3 months
of treatment. We suggest that the effect of cost in-
curred getting to treatment builds up over time, ex-
plaining this finding.
Defaulting has also been associated with male
sex10–14 and HIV positivity11,13 in studies from India,
South Africa, Ethiopia and The Gambia. In contrast,
we did not find any significant gender difference for
defaulting in our study, although after 90 days there
was a trend towards an increased rate in males (P 
0.17). The rate of defaulting from treatment has been
shown by others to be increased in patients with
EPTB, and is likely to be related to HIV positivity.15
As we did not assess HIV status under the routine
programme conditions of this study, it is a potential
source of bias. In The Gambia less than 10% of TB
patients are HIV-positive,16 although the prevalence
is likely to increase. It is the intention of the National
TB Control Programme to introduce routine HIV
testing among TB patients in the near future.
Studies in America, Canada, Hong Kong and Ethi-
opia have found older age, especially over 60 years, to
be associated with higher rates of defaulting.7,17–19 In
contrast, as has also been documented in South Af-
rica,12 we found that the 26–40 year age group ap-
peared more likely to default (in the first 90 days of
treatment, P  0.057). These differences certainly
warrant further study.
The results of this study have provided important
information for policy makers in The Gambia. We
have shown that risk groups for defaulting can be rec-
ognised at the start of treatment and are at highest
risk at different times. Since the completion of the
study, there has been some decentralisation of treat-
ment to alleviate congestion at the clinic and improve
access. Strategies to improve knowledge about TB in
ways that change basic beliefs about the likely success
of treatment will be important.20 A combination of
decentralisation and an extended range of DOT su-
pervision options has improved treatment outcomes
in Malawi.21 It may also be worthwhile to consider
‘self-supervised’ treatment after the first 3 months.22
Such a strategic, focused, mixed DOT and self treat-
ment plan would make sense, as uncertainty over
treatment success appears to decrease over time on
medications, while the toll from costs incurred in get-
ting to treatment rises.
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R É S U M É
SETTING : Polyclinique pour la tuberculose (TB) en mi-
lieu urbaine, Gambie.
OBJECTIF : Identifier les caractéristiques du patient asso-
ciées à une augmentation des taux d’abandon du traite-
ment, et spécifiquement les connaissances et les facteurs
de coût susceptibles d’être améliorés par une intervention.
SCHÉMA : Etude prospective de cohorte de cas de TB
âgés d’au moins 15 ans et commençant leur traitement,
interviewés grâce à un questionnaire semi-structuré et
suivi en ce qui concerne leur participation à un traite-
ment directement observé (DOT) administré trois fois
par semaine.
RÉSULTATS : Parmi les 301 patients, il y a eu 76 aban-
dons du traitement (25,2%) ; 25 d’entre eux ne sont pas
revenus pour le traitement. Le taux d’abandon a été plus
élevé chez ceux qui disaient avoir des doutes au sujet de
l’activité de leur traitement (HR 3,64 ; IC95% 1,42–
9,21 ; P  0,007) et chez ceux qui encouraient des coúts
significatifs en temps et en argent pour se rendre à leur
traitement (HR 2,67 ; IC95% 1,05–6,81 ; P  0,04).
Ces facteurs ont eu des effets différents à des moments
différents : l’incertitude concernant les succès du traite-
ment a été importante au cours des 90 premiers jours du
traitement, alors qu’un coût accru pour se rendre à la
polyclinique a été important après 90 jours.
CONCLUSION : En Gambie, les groupes à risque d’aban-
don peuvent être reconnus dès le début du traitement et
le risque encouru est le plus élevé à des moments dif-
férents. Il y a lieu d’envisager une auto-administration
des médicaments basée sur le domicile après 3 mois de
DOT, au moment où la confiance concernant le succès
du traitement augmente et où les coûts d’obtention du
traitement commencent à se faire ressentir.
R E S U M E N
MARCO DE REFERENCIA : Un consultorio urbano de
tuberculosis (TB), en Gambia.
OBJETIVO : Identificar las características de los pacientes,
asociadas con un alto índice de abandono del tratamiento
antituberculoso, en particular los factores relacionados
con el conocimiento de la enfermedad y los costos, sobre
los cuales puede programarse una intervención.
MÉTODO : Estudio prospectivo de cohortes de pacientes
de 15 años y más con TB, al comienzo del tratamiento.
Se practicaron entrevistas a los pacientes mediante cues-
tionarios semiestructurados y un seguimiento a fin de
evaluar la asistencia tres veces por semana al trata-
miento directamente observado (DOT).
RESULTADOS : De los 301 pacientes, 76 (25,2%) aban-
donaron el tratamiento y 25 de ellos no regresaron. La
tasa de abandono fue más alta entre quienes decían no
estar seguros de la eficacia del tratamiento que recibían
(HR 3,64 ; IC95% 1,42–9,31 ; P  0,007) y entre
quienes hicieron una inversión considerable de tiempo o
de dinero para recibir el tratamiento (HR 2,67 ; IC95%
1,05–6,81 ; P  0,04). Estos factores tuvieron efectos
diferentes según el período del tratamiento : la inseguridad
sobre el éxito del tratamiento fue importante durante los
primeros 90 días y el alto costo para acudir al consultorio
fue importante después de 90 días de tratamiento.
CONCLUSIÓN : En Gambia, los grupos de riesgo de
abandono pueden reconocerse al comienzo del trata-
miento antituberculoso y presentan su riesgo más alto en
diferentes períodos del esquema terapéutico. Se puede
pensar en la posibilidad de una auto-administración do-
miciliaria de los medicamentos después de 3 meses de
DOT, en la medida en que aumenta la confianza del pa-
ciente en el éxito del tratamiento y comienzan a ejercer
un efecto negativo los costos de desplazamiento para re-
cibir los medicamentos.
